CN1846776B - 莪术油中长链脂肪乳注射液及其制备方法 - Google Patents
莪术油中长链脂肪乳注射液及其制备方法 Download PDFInfo
- Publication number
- CN1846776B CN1846776B CN200510013309A CN200510013309A CN1846776B CN 1846776 B CN1846776 B CN 1846776B CN 200510013309 A CN200510013309 A CN 200510013309A CN 200510013309 A CN200510013309 A CN 200510013309A CN 1846776 B CN1846776 B CN 1846776B
- Authority
- CN
- China
- Prior art keywords
- injection
- oil
- water
- recipe quantity
- emulsifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002347 injection Methods 0.000 title claims abstract description 71
- 239000007924 injection Substances 0.000 title claims abstract description 71
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 240000009138 Curcuma zedoaria Species 0.000 title abstract description 14
- 235000003405 Curcuma zedoaria Nutrition 0.000 title abstract description 11
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 title abstract description 11
- 235000019509 white turmeric Nutrition 0.000 title abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 238000003756 stirring Methods 0.000 claims abstract description 25
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 20
- 238000010438 heat treatment Methods 0.000 claims abstract description 17
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 15
- 239000008215 water for injection Substances 0.000 claims abstract description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960001295 tocopherol Drugs 0.000 claims abstract description 12
- 229930003799 tocopherol Natural products 0.000 claims abstract description 12
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 12
- 239000011732 tocopherol Substances 0.000 claims abstract description 12
- 230000001105 regulatory effect Effects 0.000 claims abstract description 10
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 5
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 5
- 239000003921 oil Substances 0.000 claims description 68
- 235000019198 oils Nutrition 0.000 claims description 68
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- 239000000839 emulsion Substances 0.000 claims description 19
- 239000002960 lipid emulsion Substances 0.000 claims description 18
- 210000003022 colostrum Anatomy 0.000 claims description 17
- 235000021277 colostrum Nutrition 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 235000011187 glycerol Nutrition 0.000 claims description 9
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims description 8
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 6
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000008347 soybean phospholipid Substances 0.000 claims description 6
- 235000012424 soybean oil Nutrition 0.000 claims description 5
- 239000003549 soybean oil Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 238000007670 refining Methods 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 3
- 235000019485 Safflower oil Nutrition 0.000 claims description 3
- 230000003204 osmotic effect Effects 0.000 claims description 3
- 229920001983 poloxamer Polymers 0.000 claims description 3
- 229960000502 poloxamer Drugs 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000001727 glucose Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 125000002640 tocopherol group Chemical group 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- -1 isoosmotic regulator Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940090044 injection Drugs 0.000 description 51
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 239000012071 phase Substances 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 238000004945 emulsification Methods 0.000 description 7
- 210000003462 vein Anatomy 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000012856 packing Methods 0.000 description 6
- 244000163122 Curcuma domestica Species 0.000 description 5
- 235000003392 Curcuma domestica Nutrition 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 235000003373 curcuma longa Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000013976 turmeric Nutrition 0.000 description 5
- 239000003643 water by type Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000010681 turmeric oil Substances 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229940093181 glucose injection Drugs 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- KDPFMRXIVDLQKX-ISGXEFFDSA-N (+)-Curdione Natural products CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)/CC1=O KDPFMRXIVDLQKX-ISGXEFFDSA-N 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 241000407170 Curcuma Species 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- ZVMJXSJCBLRAPD-ZFWWWQNUSA-N Curzerenone Chemical compound C1[C@@](C=C)(C)[C@@H](C(=C)C)C(=O)C2=C1OC=C2C ZVMJXSJCBLRAPD-ZFWWWQNUSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- ZVMJXSJCBLRAPD-UHFFFAOYSA-N Epicurzerenone Natural products C1C(C=C)(C)C(C(=C)C)C(=O)C2=C1OC=C2C ZVMJXSJCBLRAPD-UHFFFAOYSA-N 0.000 description 1
- KDPFMRXIVDLQKX-NHFJXKHHSA-N Germacr-1(10)-ene-5,8-dione Chemical compound CC(C)[C@@H]1CC(=O)[C@@H](C)CC\C=C(C)\CC1=O KDPFMRXIVDLQKX-NHFJXKHHSA-N 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010035737 Pneumonia viral Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002223 anti-pathogen Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- KDPFMRXIVDLQKX-UHFFFAOYSA-N curdione Natural products CC(C)C1CC(=O)C(C)CCC=C(C)CC1=O KDPFMRXIVDLQKX-UHFFFAOYSA-N 0.000 description 1
- QUQIBYMETMROHZ-UHFFFAOYSA-N curzerenone Natural products CCC1(C)Cc2occ(C)c2C(=O)C1C(C)C QUQIBYMETMROHZ-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000010494 opalescence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 208000009421 viral pneumonia Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510013309A CN1846776B (zh) | 2005-04-12 | 2005-04-12 | 莪术油中长链脂肪乳注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510013309A CN1846776B (zh) | 2005-04-12 | 2005-04-12 | 莪术油中长链脂肪乳注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1846776A CN1846776A (zh) | 2006-10-18 |
CN1846776B true CN1846776B (zh) | 2010-05-12 |
Family
ID=37076657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200510013309A Expired - Fee Related CN1846776B (zh) | 2005-04-12 | 2005-04-12 | 莪术油中长链脂肪乳注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1846776B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552133A (zh) * | 2010-12-15 | 2012-07-11 | 清远嘉博制药有限公司 | 中/长链甘油三酸酯氟比洛芬酯注射液及其制备方法 |
CN103301062A (zh) * | 2013-06-03 | 2013-09-18 | 四川百利药业有限责任公司 | 一种中长链脂肪乳注射液的制备方法 |
CN105942510A (zh) * | 2016-05-24 | 2016-09-21 | 北京诺康达医药科技有限公司 | 一种应用于孕产妇的医用能量营养组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562174A (zh) * | 2004-03-18 | 2005-01-12 | 四川科伦药业股份有限公司 | 莪术油注射乳剂及其制备方法 |
-
2005
- 2005-04-12 CN CN200510013309A patent/CN1846776B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1562174A (zh) * | 2004-03-18 | 2005-01-12 | 四川科伦药业股份有限公司 | 莪术油注射乳剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
潘雁.全静脉营养液质量控制的研究进展.药学服务与研究4 4.2004,4(4),348-351. |
潘雁.全静脉营养液质量控制的研究进展.药学服务与研究4 4.2004,4(4),348-351. * |
Also Published As
Publication number | Publication date |
---|---|
CN1846776A (zh) | 2006-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101022786B (zh) | 用自乳化制剂释放亲脂性辅酶Q10(CoQ10)及其他膳食组分 | |
CN1895239B (zh) | 一种姜黄素制剂及其制备方法 | |
CN101708314B (zh) | 一种中药挥发油注射溶液及其注射剂和制备方法 | |
CN100569294C (zh) | 一种静脉注射用高稳定长循环脂肪乳载药制剂 | |
CN106456541A (zh) | 纳米乳传递系统组合物 | |
CN101288642B (zh) | 一种紫杉烷类药物静脉给药制剂及其制备方法 | |
CN100375621C (zh) | 长春瑞滨脂质微球注射液及其制备方法 | |
US10166187B2 (en) | Curcumin solid lipid particles and methods for their preparation and use | |
Bhatia et al. | A review on multiple emulsions | |
CN101524329B (zh) | 双环醇亚微乳及其制备方法 | |
TWI598093B (zh) | 含有高濃度輔酶q10的安定組成物 | |
WO2012146057A1 (zh) | 一种姜黄素类化合物注射溶液及其静脉注射剂 | |
CN105616710A (zh) | 一种茶籽油脂肪乳注射液及其制备方法与应用 | |
CN1985851B (zh) | 含有蟾酥提取物的脂质微球注射液及其制备方法 | |
CN1846776B (zh) | 莪术油中长链脂肪乳注射液及其制备方法 | |
CN102846552B (zh) | 多西他赛脂质纳米粒的制备和应用 | |
CN101474150B (zh) | 一种稳定的前列地尔注射乳液及其制备方法 | |
CN100515389C (zh) | 一种适用于难溶性药物的药用乳剂及其制备方法 | |
CN101491550B (zh) | 一种红曲提取物与辅酶q10复方制剂的制备方法 | |
CN101332176A (zh) | 一种桂利嗪脂质微球注射用药物组合物及其制备方法 | |
CN101011373A (zh) | 一种含左卡尼汀的药物组合物及其制备方法 | |
CN105147609A (zh) | 己烯雌酚脂肪乳注射液 | |
CN105832744B (zh) | 一种供注射用的前列地尔冻干乳剂组合物 | |
CN102949415B (zh) | 一种蜂胶脂肪乳制剂及其制备方法 | |
Lokhande | Recent Trends in Multiple Emulsion-A Comprehensive Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin City, Beichen science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100512 Termination date: 20180412 |